Ads
related to: Psoriatic Arthritis and Inflammatory Conditions- Explore Savings Options
Sign Up For Information, Updates,
& A $0 Co-Pay Savings Offer.
- Treatment FAQs
Get Answers To Frequently Asked
Questions About Our Treatment.
- Discussion Guide
Questions To Ask Before Seeing Your
Doctor To Talk About Treatment.
- Treatment Cost Info
Find Information On Paying For
Our Psoriatic Arthritis Treatment.
- Explore Savings Options
Search results
Does the Anti-Inflammatory Diet for Psoriasis Help Manage Symptoms?
Verywell Health via Yahoo News· 5 days agoInflammation is one of the underlying causes of psoriasis, and research shows that an anti-...
Guselkumab Provides Long-Term Relief From PsA Symptoms
Medscape· 1 week agoGuselkumab improved joint swelling, spinal pain, skin symptoms, and overall disease activity in a...
Two Biosimilars Approved in Europe for Autoimmune Disorders
Medscape· 22 hours agoThe drugs are intended to treat several types of arthritis, psoriasis, COVID-19, and Crohn's...
Arthritis Medications: NSAIDs, Steroids, Narcotics, Topical Treatments, and More
WebMD· 1 day agoThere are dozens of medications available with or without a prescription to treat the various forms of arthritis. Nonsteroidal anti-inflammatory drugs or NSAIDs are available both over the counter and by prescription.
Rinvoq interactions: Other medications, alcohol, and more
Medical News Today· 2 weeks agoRinvoq (upadacitinib) is a brand-name extended-release oral tablet prescribed for certain autoimmune...
Joint Pain in Big Toe: Possible Causes and Treatment
Healthline· 5 days agoConsider the following possible causes of joint pain in your big toe, including symptoms, risk factors, and prevention strategies. A type of arthritis,...
What To Know and Do About Back Pain
Health via Yahoo News· 2 weeks agoBack pain can be debilitating. Understanding its causes, treatment options, and prevention strategies can help manage pain and improve quality of life.
FDA Approves Second Ustekinumab Biosimilar
Medscape· 1 week agoThe biosimilar is expected to be marketed in the United States on or after February 21, 2025.
Sandoz confirms European Commission approval of Pyzchiva® (ustekinumab), further strengthening...
Morningstar· 5 days agoAd hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Pyzchiva® approved as one of first ustekinumab biosimilars in EuropeEC approval based on robust development program confirming match to reference medicine in terms of safety
Option Care Health (OPCH) to Release Earnings on Tuesday
ETF DAILY NEWS· 6 days agoOption Care Health (NASDAQ:OPCH – Get Free Report) will post its quarterly earnings results before the market opens on Tuesday, April 23rd. Analysts expect Option Care Health to post earnings ...
Ads
related to: Psoriatic Arthritis and Inflammatory Conditions